References

  1. Institute of Medicine, US National Academy of Sciences. November 1999. To Err Is Human: Building a Safer Health System. http://www.iom.edu/Object.File/Master/4/117/ToErr-8pager.pdf (accessed January 25, 2009).
  2. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. Last updated July 31, 2002. http://www.fda.gov/cder/drug/drugReactions/default.htm#ADRs:%20Prevalence%20and%20Incidence (accessed January 25, 2009).
  3. Furberg, C. D., A. A. Levin, P. A. Gross, R. S. Shapiro, and B. L. Strom. 2006. The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med 166 (18):1938–42.
  4. Gordon S. Antibiotics still prescribed too often, includes interview with expert Dr. Philip Tierno, originally published by Health Day News, November 8, 2005, reprinted by PharmDaily.com. http://www.pharmdaily.com/Article/1722/Antibiotics_Still_Prescribed_Too_Often.html?CategoryID=29 (accessed January 25, 2009).
  5. U.S. Centers for Disease Control and Prevention (CDC). It’s Time to Get Smart about the Use of Antibiotics: CDC campaign aims to draw attention to the increasing problem of antibiotic resistance, (Press Release), CDC, October 2, 2008. http://www.cdc.gov/media/pressrel/2008/r081002.htm (accessed January 25, 2009).
  6. US National Center for Health Statistics. Deaths: final Data for 2005. National Vital Statistics Report, vol. 56, no. 10, April 24, 2008. http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf (accessed January 24, 2009).
  7. National Cancer Institute, US National Institutes of Health. Cancer Statistics (projection for 2008), Surveillance, Epidemiology and End Results (SEER) Stat Fact Sheets, “based on November 2007 SEER data submission, posted to the SEER web site, 2008.” http://seer.cancer.gov/statfacts/html/all.html (accessed January 23, 2009).
  8. US Senate Finance Committee. Testimony of David J. Graham, MD, MPH, November 18, 2004. http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf (accessed January 30, 2009).
  9. Ibid.
  10. Alonso-Zaldivar, R., FDA Called ‘Defenseless’ Against Unsafe Drugs, Los Angeles Times, November 18, 2004. http://www.mcall.com/topic/la-111804vioxx_lat,0,7473253.story (accessed January 31, 2009).
  11. US Senate Finance Committee. Testimony of David J. Graham, MD, MPH, November 18, 2004. http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf (accessed January 30, 2009).
  12. National Coalition Against Censorship. FDA Suppressed Vioxx Studies Despite Evidence of Serious Health Risks, November 25, 2004. http://www.ncac.org/FDA_Suppressed_Vioxx_Studies (accessed January 30, 2009).
  13. Bailey Esq, B., Bad medicine, Texas Injury Law, July 27, 2008. http://www.txinjurylawblog.com/tags/drugs-accolate-accutane-arava-1/ (accessed January 30, 2009).
  14. Alonso-Zaldivar, R., “FDA Called ‘Defenseless’ Against Unsafe Drugs,” Los Angeles Times, November 18, 2004. http://www.mcall.com/topic/la-111804vioxx_lat,0,7473253.story (accessed January 31, 2009).
  15. Associated Press. F.D.A. Called ‘Defenseless’ Against Unsafe Drugs, New York Times, 18 November 2004. http://biopsychiatry.com/bigpharma/fda.html (accessed January 31, 2009).
  16. Yale Medicine. FDA’s top safety critic keeps a watchful eye on the public good, Summer 2005. http://yalemedicine.yale.edu/ym_su05/faces.html (accessed January 31, 2009).
  17. Young, D., Safety Experts Call for Accountability from FDA, Drug Firms. American Society of Health-System Pharmacists, March 23, 2007. http://www.ashp.org/import/News/HealthSystemPharmacyNews/newsarticle.aspx?id=2503 (accessed January 31, 2009).
  18. Ibid.
  19. Loudon, Manette, interviewer. The FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower, parts of this interview appear in Gary Null’s documentary film, Prescription for Disaster, Garynull.com, August 30, 2005, reprinted by Natural News. http://www.naturalnews.com/011401.html (accessed January 31, 2009).
  20. US Senate Finance Committee. Testimony of David J. Graham, MD, MPH, November 18, 2004. http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf (accessed January 30, 2009).
  21. Yale Medicine. FDA’s top safety critic keeps a watchful eye on the public good, Summer 2005. http://yalemedicine.yale.edu/ym_su05/faces.html (accessed January 31, 2009).
  22. Alonso-Zaldivar, R., FDA Called ‘Defenseless’ Against Unsafe Drugs, Los Angeles Times, November 18, 2004. http://www.mcall.com/topic/la-111804vioxx_lat,0,7473253.story (accessed January 31, 2009).
  23. Kelly, J. Harsh criticism lobbed at FDA in Senate Vioxx hearing, Medscape Medical News, November 23, 2004. http://medgenmed.medscape.com/viewarticle/538021_print (accessed January 31, 2009).
  24. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  25. Ibid.
  26. Gurwitz, J. H., T. S. Field, J. Avorn, D. McCormick, S. Jain, M. Eckler, M. Benser, A. C. Edmondson, and D. W. Bates. 2000. Incidence and preventability of adverse drug events in nursing homes. Am J Med 109 (2):87–94.
  27. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. Last updated July 31, 2002. http://www.fda.gov/cder/drug/drugReactions/default.htm#ADRs:%20Prevalence%20and%20Incidence (accessed January 25, 2009).
  28. Rabin R. Caution about overuse of antibiotics. Newsday. September 18, 2003.
  29. Available at: http://www.cdc.gov/drugresistance/community/ (Accessed May 22, 2006).
  30. Gordon S. Antibiotics still prescribed too often, includes interview with expert Dr. Philip Tierno, originally published by Health Day News, November 8, 2005, reprinted by PharmDaily.com. http://www.pharmdaily.com/Article/1722/Antibiotics_Still_Prescribed_Too_Often.html?CategoryID=29 (accessed January 25, 2009).
  31. U.S. Centers for Disease Control and Prevention (CDC). It’s Time to Get Smart about the Use of Antibiotics: CDC campaign aims to draw attention to the increasing problem of antibiotic resistance, (Press Release), CDC, October 2, 2008. http://www.cdc.gov/media/pressrel/2008/r081002.htm (accessed January 25, 2009).
  32. Ibid.
  33. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  34. US Congressional House Subcommittee Oversight Investigation. Cost and Quality of Health Care: Unnecessary Surgery. Washington, DC: Government Printing Office; 1976. Cited in: McClelland GB, Foundation for Chiropractic Education and Research. Testimony to the Department of Veterans Affairs’ Chiropractic Advisory Committee. March 25, 2003.
  35. http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  36. Siu, A. L., F. A. Sonnenberg, W. G. Manning, G. A. Goldberg, E. S. Bloomfield, J. P. Newhouse, and R. H. Brook. 1986. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med 315 (20):1259–66.
  37. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  38. Eriksen, B. O., I. S. Kristiansen, E. Nord, J. F. Pape, S. M. Almdahl, A. Hensrud, and S. Jaeger. 1999. The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med 246 (4):379–87.
  39. National Coalition on Health Care. “Did You Know?” section of home page of NCHC, 2009. http://www.nchc.org/ (accessed January 27, 2009).
  40. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  41. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Morbidity and Mortality Weekly Report. February 25, 2000, Vol. 49, No. 7, p. 138.
  42. Centers for Disease Control and Prevention. Estimates of Healthcare-Associated Infections, last modified May 30, 2007. http://www.cdc.gov/ncidod/dhqp/hai.html (accessed January 24, 2009).
  43. Ibid.
  44. Klevens, R. Monina DDS, MPH, Jonathan R. Edwards, MS, Chesley L. Richards, Jr., MD, MPH, Teresa C. Horan, MPH, Robert P. Gaynes, MD, Daniel A. Pollock, MD, Denise M. Cardo, MD. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002, Public Health Reports, Volume 122, March–April 2007. http://www.cdc.gov/ncidod/dhqp/pdf/hicpac/infections_deaths.pdf (accessed January 27, 2009).
  45. US National Center for Health Statistics. Deaths: final Data for 2005. National Vital Statistics Report, vol. 56, no. 10, April 24, 2008. http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf (accessed January 24, 2009).
  46. Wyden, Ron Senator, The Healthy Americans Act. “$2.2 trillion currently spent on health care in America today.” http://wyden.senate.gov/issues/Legislation/Healthy_Americans_Act.cfm (accessed January 26, 2009).
  47. National Coalition on Health Care. Economic Cost Fact Sheets: The Impact of Rising Health Care Costs on the Economy, NCHC, 2009. http://www.nchc.org/facts/economic.shtml (accessed January 27, 2009).
  48. Wyden, Ron Senator, The Healthy Americans Act. “$2.2 trillion currently spent on health care in America today.” http://wyden.senate.gov/issues/Legislation/Healthy_Americans_Act.cfm (accessed January 26, 2009).
  49. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. JAMA 279 (15):1200–5.
  50. Suh, D. C., B. S. Woodall, S. K. Shin, and E. R. Hermes-De Santis. 2000. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 34 (12):1373–9.
  51. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. Last updated July 31, 2002. http://www.fda.gov/cder/drug/drugReactions/default.htm#ADRs:%20Prevalence%20and%20Incidence (accessed January 25, 2009).
  52. Institute of Medicine, US National Academy of Sciences. November 1999. To Err Is Human: Building a Safer Health System. http://www.iom.edu/Object.File/Master/4/117/ToErr-8pager.pdf (accessed January 25, 2009).
  53. Thomas, E. J., D. M. Studdert, H. R. Burstin, E. J. Orav, T. Zeena, E. J. Williams, K. M. Howard, P. C. Weiler, and T. A. Brennan. 2000. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 38 (3):261–71.
  54. Thomas, E. J., D. M. Studdert, J. P. Newhouse, B. I. Zbar, K. M. Howard, E. J. Williams, and T. A. Brennan. 1999. Costs of medical injuries in Utah and Colorado. Inquiry 36 (3):255–64.
  55. Xakellis, G. C., R. Frantz, and A. Lewis. 1995. Cost of pressure ulcer prevention in long-term care. J Am Geriatr Soc 43 (5):496–501.
  56. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Bosley. 1997. Fourth national pressure ulcer prevalence survey. Adv Wound Care 10 (4):18–26.
  57. Health Grades Quality Study, Patient Safety in American Hospitals, July 2004. http://www.healthgrades.com/media/english/pdf/hg_patient_safety_study_final.pdf (accessed March 3, 2009).
  58. Centers for Disease Control and Prevention. Estimates of Healthcare-Associated Infections, last modified May 30, 2007. http://www.cdc.gov/ncidod/dhqp/hai.html (accessed January 24, 2009).
  59. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  60. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Morbidity and Mortality Weekly Report. February 25, 2000, Vol. 49, No. 7, p. 138.
  61. Starfield, B. 2000. Is US health really the best in the world? JAMA 284 (4):483–5.
  62. Nursing Home Residents Dying of Hunger, Thirst. Consumer Affairs, November 29, 2004. http://www.consumeraffairs.com/news04/nursing_home_neglect.html (accessed March 4, 2009).
  63. Starfield, B. 2000. Deficiencies in US medical care. JAMA 284 (17):2184–5.
  64. Weingart, S. N., L. Wilson R. Mc, R. W. Gibberd, and B. Harrison. 2000. Epidemiology of medical error. West J Med 172 (6):390–3.
  65. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  66. Thomas, E. J., D. M. Studdert, J. P. Newhouse, B. I. Zbar, K. M. Howard, E. J. Williams, and T. A. Brennan. 1999. Costs of medical injuries in Utah and Colorado. Inquiry 36 (3):255–64.
  67. Available at: http://www.ahrq.gov/news/ ress/pr2003/injurypr.htm. (Accessed May 22, 2006).
  68. Leape LL.Unnecessary surgery.Health Serv Res. 1989 Aug; 24(3):351–407.
  69. National Coalition on Health Care. Health Insurance Costs: Facts on the Cost of Health Insurance and Health Care, NCHC, 2009. http://www.nchc.org/facts/cost.shtml (accessed January 28, 2009).
  70. National Coalition on Health Care. “Did You Know?” section of home page of NCHC, 2009. http://www.nchc.org/ (accessed January 27, 2009).
  71. National Coalition on Health Care. Health Insurance Costs: Facts on the Cost of Health Insurance and Health Care, NCHC, 2009. http://www.nchc.org/facts/cost.shtml (accessed January 28, 2009).
  72. National Coalition on Health Care. “Did You Know?” section of home page of NCHC, 2009. http://www.nchc.org/ (accessed January 27, 2009).
  73. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  74. National Patient Safety Foundation. Nationwide poll on patient safety: 100 million Americans see medical mistakes directly touching them [press release]. McLean, VA: October 9, 1997.
  75. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  76. National Patient Safety Foundation. Nationwide poll on patient safety: 100 million Americans see medical mistakes directly touching them [press release]. McLean, VA: October 9, 1997.
  77. Ibid.
  78. Xakellis, G. C., R. Frantz, and A. Lewis. 1995. Cost of pressure ulcer prevention in long-term care. J Am Geriatr Soc 43 (5):496–501.
  79. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Bosley. 1997. Fourth national pressure ulcer prevalence survey. Adv Wound Care 10 (4):18–26.
  80. Centers for Disease Control and Prevention. Estimates of Healthcare-Associated Infections, last modified May 30, 2007. http://www.cdc.gov/ncidod/dhqp/hai.html (accessed January 24, 2009).
  81. Health Grades Quality Study, Patient Safety in American Hospitals, July 2004. http://www.healthgrades.com/media/english/pdf/hg_patient_safety_study_final.pdf (accessed March 3, 2009).
  82. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  83. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Morbidity and Mortality Weekly Report. February 25, 2000, Vol. 49, No. 7, p. 138.
  84. Available at: http://www.cmwf.org/programs/elders/burger_mal_386.asp. (accessed May 22, 2006).
  85. Starfield, B. 2000. Is US health really the best in the world? JAMA 284 (4):483–5.
  86. Starfield, B. 2000. Deficiencies in US medical care. JAMA 284 (17):2184–5.
  87. Weingart, S. N., L. Wilson R. Mc, R. W. Gibberd, and B. Harrison. 2000. Epidemiology of medical error. West J Med 172 (6):390–3.
  88. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  89. Available at: http://www.ahrq.gov/news/ ress/pr2003/injurypr.htm. (Accessed May 22, 2006).
  90. Leape LL.Unnecessary surgery. Health Serv Res. 1989 Aug;24(3):351–407.
  91. Peck, P. Patient safety requires fundamental changes to medical systems. Medscape Medical News, 6 May 2004. http://www.medscape.com/viewarticle/475217 (accessed January 28, 2009).
  92. Altman, LK. Even the elite hospitals aren’t immune to errors. New York Times, 23 February 2003. http://query.nytimes.com/gst/fullpage.html?res=9C0DE3D9113DF930A15751C0A9659C8B63&n=Top/Reference/Times%20Topics/People/S/Santillan,%20Jesica&scp=1&sq=Altman%20LK.%20Even%20the%20elite%20hospitals%20aren%E2%80%99t%20immune%20to%20errors.%20New%20York%20Times,%2023%20February%202003&st=cse (accessed January 28, 2009).
  93. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  94. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  95. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  96. LaPointe, N. M., and J. G. Jollis. 2003. Medication errors in hospitalized cardiovascular patients. Arch Intern Med 163 (12):1461–6.
  97. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  98. Institute of Medicine, US National Academy of Sciences. November 1999. To Err Is Human: Building a Safer Health System. http://www.iom.edu/Object.File/Master/4/117/ToErr-8pager.pdf (accessed January 25, 2009).
  99. Center for Drug Evaluation and Research.U.S.Food and Drug Administration.Preventable Adverse Drug Reactions: A Focus on Drug Interactions. Last updated July 31,2002. http://www.fda.gov/cder/drug/drugReactions/default.htm#ADRs:%20Pr evalence%20and%20Incidence (accessed January 25, 2009).
  100. Thomas, E. J., D. M. Studdert, H. R. Burstin, E. J. Orav, T. Zeena, E. J. Williams, K. M. Howard, P. C. Weiler, and T. A. Brennan. 2000. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 38 (3):261–71.
  101. Thomas, E. J., D. M. Studdert, J. P. Newhouse, B. I. Zbar, K. M. Howard, E. J. Williams, and T. A. Brennan. 1999. Costs of medical injuries in Utah and Colorado. Inquiry 36 (3):255–64.
  102. Xakellis, G. C., R. Frantz, and A. Lewis. 1995. Cost of pressure ulcer prevention in long-term care. J Am Geriatr Soc 43 (5):496–501.
  103. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Bosley. 1997. Fourth national pressure ulcer prevalence survey. Adv Wound Care 10 (4):18–26.
  104. Centers for Disease Control and Prevention. Estimates of Healthcare-Associated Infections, last modified May 30, 2007. http://www.cdc.gov/ncidod/dhqp/hai.html (accessed January 24, 2009).
  105. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  106. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Morbidity and Mortality Weekly Report. February 25, 2000, Vol. 49, No. 7, p. 138.
  107. Available at: http://www.cmwf.org/programs/elders/burger_mal_386.asp. (accessed May 22, 2006).
  108. Starfield, B. 2000. Is US health really the best in the world? JAMA 284 (4):483–5.
  109. Starfield, B. 2000. Deficiencies in US medical care. JAMA 284 (17):2184–5.
  110. Weingart, S. N., L. Wilson R. Mc, R. W. Gibberd, and B. Harrison. 2000. Epidemiology of medical error. West J Med 172 (6):390–3.
  111. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  112. Available at: http://www.ahrq.gov/news/ ress/pr2003/injurypr.htm. (Accessed May 22, 2006).
  113. http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  114. Siu, A. L., F. A. Sonnenberg, W. G. Manning, G. A. Goldberg, E. S. Bloomfield, J. P. Newhouse, and R. H. Brook. 1986. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med 315 (20):1259–66.
  115. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  116. Eriksen, B. O., I. S. Kristiansen, E. Nord, J. F. Pape, S. M. Almdahl, A. Hensrud, and S. Jaeger. 1999. The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med 246 (4):379–87.
  117. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  118. The Society of Actuaries Health Benefit Systems Practice Advancement Committee. The Troubled Healthcare System in the US. September 13, 2003. Available at: http://www.soa.org/sections/troubled_healthcare.pdf. (accessed December 18, 2003).
  119. National Coalition on Health Care. Health Insurance Costs: Facts on the Cost of Health Insurance and Health Care, NCHC, 2009. http://www.nchc.org/facts/cost.shtml (accessed January 28, 2009).
  120. Shafrin, J., Ph.D. candidate in Economics at UC, U.S. spends $700 billion on unnecessary medical tests, Healthcare Economist, November 7, 2008. http://healthcare-economist.com/2008/11/07/us-spends-700-billion-on-unnecessary-medical-tests/ (accessed January 28, 2009).
  121. Berenson, A. and R. Abelson, The Evidence Gap: Weighing the Costs of a CT Scan’s Look Inside the Heart, New York Times, June 29, 2008. http://www.nytimes.com/2008/06/29/business/29scan.html?_r=1&ei=5087&em=&en=fe03ca7fee00b38f&ex=1214971200&adxnnl=1&adxnnlx=1214838413-Ndu72SwNDujyHmtVwDa+AA (accessed January 28, 2009).
  122. National Coalition for Health Care. 2009. Facts on Health Insurance Coverage. http://www.nchc.org/facts/coverage.shtml (accessed January 31, 2009).
  123. Ibid.
  124. Families USA. Wrong Direction: One Out of Three Americans are Uninsured. September 2007. http://familiesusa.org/assets/pdfs/wrong-direction.pdf (accessed January 31, 2009).
  125. National Coalition for Health Care. 2009. Facts on Health Insurance Coverage. http://www.nchc.org/facts/coverage.shtml (accessed January 31, 2009).
  126. Ibid.
  127. Alonso-Zaldivar, R. Getting married for health insurance, Los Angeles Times, April 29, 2008. http://articles.latimes.com/2008/apr/29/nation/na-health29 (accessed January 31, 2009).
  128. Alonso-Zaldivar, R. Getting married for health insurance, Los Angeles Times, April 29, 2008. http://articles.latimes.com/2008/apr/29/nation/na-health29 (accessed January 31, 2009).
  129. Institute of Medicine. Care Without Coverage: Too Little, Too Late. May 21, 2002. A Shared Destiny: Community Effects of Uninsurance. March 6, 2003.
  130. US Department of Health and Human Services and US Department of Justice. Health Care Fraud and Abuse Control Program Annual Report for FY 1998. April 1999. Health Care Fraud and Abuse Control Program Annual Report for FY 2001. April 2002.
  131. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  132. Bates, D. W., D. J. Cullen, N. Laird, L. A. Petersen, S. D. Small, D. Servi, G. Laffel, B. J. Sweitzer, B. F. Shea, R. Hallisey, and et al. 1995. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274 (1):29–34.
  133. Vincent, C., N. Stanhope and M. Crowley-Murphy. Reasons for not reporting adverse incidents: an empirical study. J Eval Clin Pract. 1999 Feb;5(1):13–21.
  134. Bates, DW. Drugs and adverse drug reactions: how worried should we be? JAMA. 1998 Apr 15;279(15):1216–7.
  135. Dickinson, JG. FDA seeks to double effort on confusing drug names. Dickinson’s FDA Review. 2000 Mar;7(3):13–4.
  136. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  137. Campbell, E. G., J. S. Weissman, B. Clarridge, R. Yucel, N. Causino, and D. Blumenthal. 2003. Characteristics of medical school faculty members serving on institutional review boards: results of a national survey. Acad Med 78 (8):831–6.
  138. HealthDayNews. Possible conflict of interest within medical profession. August 15, 2003.
  139. Harris, G. F.D.A. Limits Role of Advisers Tied to Industry, The New York Times, March 22, 2007. http://www.nytimes.com/2007/03/22/washington/22fda.html (accessed January 26, 2009).
  140. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  141. Brennan, T. A., L. L. Leape, N. M. Laird, L. Hebert, A. R. Localio, A. G. Lawthers, J. P. Newhouse, P. C. Weiler, and H. H. Hiatt. 1991. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324 (6):370–6.
  142. Bates, D. W., D. J. Cullen, N. Laird, L. A. Petersen, S. D. Small, D. Servi, G. Laffel, B. J. Sweitzer, B. F. Shea, R. Hallisey, and et al. 1995. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274 (1):29–34.
  143. National Patient Safety Foundation. Nationwide poll on patient safety: 100 million Americans see medical mistakes directly touching them [press release]. McLean, VA: October 9, 1997.
  144. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  145. Kotulak, R. Doctors’ haste seen hurting patient: study says the push for quick treatment detracts from care. Chicago Tribune online edition, 10 May 2005. http://www.chicagotribune.com/features/health/ (no longer available here); available at Committee for Justice for All: Patient Safety and Doctor Discipline, CJA President Attorney Peter I. Fallk, Dr. Persell quote is on website. http://www.saynotocaps.org/patientsafety.shtml (accessed January 28, 2009).
  146. Leape, L. L. 1994. Error in medicine. JAMA 272 (23):1851–7.
  147. Vincent, C., N. Stanhope and M. Crowley-Murphy. Reasons for not reporting adverse incidents: an empirical study. J Eval Clin Pract. 1999 Feb;5(1):13–21.
  148. Wald, H., Shojania, K.G. Incident reporting. In: Shojania, K.G., Duncan, B.W., McDonald, K.M., et al, eds. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Rockville, MD: Agency for Healthcare Research and Quality; 2001:chapter 4. Evidence Report/Technology Assessment No. 43. AHRQ publication 01-E058.
  149. Grinfeld, M.J. The debate over medical error reporting. Psychiatric Times. April 2000.
  150. Ibid.
  151. King, G. III, A. Hermodson. 2000. Peer reporting of coworker wrongdoing: a qualitative analysis of observer attitudes in the decision to report versus not report unethical behavior. Journal of Applied Communication Research (28), 309–29.
  152. Stenson, J. Few residents report medical errors, survey finds. Reuters Health. February 21, 2003.
  153. Agency for Healthcare Research and Quality. Underreporting of medical errors affecting children is a significant problem, particularly among physicians. http://www.ahrq.gov/research/dec04/1204RA7.htm (accessed January 29, 2009).
  154. Taylor, J.A., D. Brownstein, D.A. Christakis, S. Blackburn, T.P. Strandjord, E.J. Klein and J. Shafii. Use of incident reports by physicians and nurses to document medical errors in pediatric patients. Pediatrics 114(3):Sept 2004, pp. 729–735; http://pediatrics.aappublications.org/cgi/content/abstract/114/3/729 (accessed January 29, 2009).
  155. Indiana University School of Medicine, WFYI 90.1 FM radio program, host Jeremy Shere, “Doctors Don’t Report Medical Errors,” interview with Lauris Kaldjian, M.D., Ph.D., Director of Bioethics Program of U. Iowa, to discuss his report on medical errors, which appears in the Jan. 14, 2008 issue of Archives of Internal Medicine, on “Sound Medicine Checkup,” aired on February 17, 2008. http://soundmedicine.iu.edu/segment.php4?seg=1522 (accessed January 28, 2009).
  156. Blendon, R. J., C. Schoen, C. M. DesRoches, R. Osborn, K. L. Scoles, and K. Zapert. 2002. Inequities in health care: a five-country survey. Health Aff (Millwood) 21 (3):182–91.
  157. Harvard School of Public Health. Survey by Henry J. Kaiser Family Foundation, Methodology: Fieldwork conducted by ICR–International Communications Research, April 11–June 11, 2002.
  158. Patient Safety and Quality Improvement Act of 2005. Pub L 109–41. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_public_laws&docid=f:publ041.109.pdf (accessed January 29, 2009).
  159. The Patient Safety and Quality Improvement Act of 2005. Overview, June 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/qual/psoact.htm (accessed January 29, 2009).
  160. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  161. Tauber, Michelle. The Quaid Twins ‘Fighting for Their Lives’: Dennis and Kimberly Quaid Keep Vigil as Their Newborns Struggle to Survive a Devastating Hospital Error That Resulted in an Overdose of Blood Thinner, People Magazine, vol.68, no.24, December 10, 2007. http://www.people.com/people/archive/article/0,,20170884,00.html (accessed January 29, 2009).
  162. ScienceDaily. Largest Ever Prospective Medical Study Shows Epidurals And Spinal Anesthetics Are Safer Than Previously Reported [in Britain], ScienceDaily, January 16, 2009. http://www.sciencedaily.com/releases/2009/01/090113074445.htm (accessed February 1, 2009).
  163. FAQ’s: Anesthesia and Brain Monitoring: What are the risks of anesthesia? Aspect Medical Systems, 2009. http://www.aspectmedical.com/patients/anesthesia-risks.mspx (accessed February 1, 2009).
  164. Bond, C. A., C. L. Raehl, and T. Franke. 2002. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 22 (2):134–47.
  165. Barker, K. N., E. A. Flynn, G. A. Pepper, D. W. Bates, and R. L. Mikeal. 2002. Medication errors observed in 36 health care facilities. Arch Intern Med 162 (16):1897–903.
  166. LaPointe, N. M., and J. G. Jollis. 2003. Medication errors in hospitalized cardiovascular patients. Arch Intern Med 163 (12):1461–6.
  167. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  168. Ibid.
  169. Available at: www.msnbc.com/news/ 937302.asp?cp1=1. (accessed May 22, 2006).
  170. Lasser, K. E., P. D. Allen, S. J. Woolhandler, D. U. Himmelstein, S. M. Wolfe, and D. H. Bor. 2002. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287 (17):2215–20.
  171. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  172. Gandhi, T. K., S. N. Weingart, J. Borus, A. C. Seger, J. Peterson, E. Burdick, D. L. Seger, K. Shu, F. Federico, L. L. Leape, and D. W. Bates. 2003. Adverse drug events in ambulatory care. N Engl J Med 348 (16):1556–64.
  173. Reuters. Medication side effects strike 1 in 4. April 17, 2003.
  174. Rosen, M. Top 20 big pharmas represent majority of world pharma market. Wisconsin Technology Network; data drawn from Pharmaceutial Executive, May 2005 (IMS Health data). http://wistechnology.com/article.php?id=1903 (accessed January 29, 2009).
  175. Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor. Goodman and Gilman’s The Pharma-cological Basis of Therapeutics. (New York: Pergamon Press; 1996).
  176. Kolata, G. New York Times News Service. Who cares when our drugs fail? San Diego Union-Tribune, October 15, 1997:E-1,5.
  177. Melmon, K.L., H.F. Morrelli, B.B. Hoffman and D.W. Nierenberg, eds. Melmon and Morrelli’s Clinical Pharmacology: Basic Principles in Therapeutics. 3rd ed. (New York: McGraw-Hill, Inc., 1992).
  178. Cullen, D. J., D. W. Bates, S. D. Small, J. B. Cooper, A. R. Nemeskal, and L. L. Leape. 1995. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 21 (10):541–8.
  179. Bates, DW. Drugs and advrse drug reactions: how worried should we be? JAMA. 1998 Apr 15;279(15):1216–7.
  180. Dickinson, JG. FDA seeks to double effort on confusing drug names. Dickinson’s FDA Review. 2000 Mar;7(3):13–4.
  181. Cohen, J.S. Overdose: The Case Against the Drug Companies. (New York: Tarcher-Putnum, 2001).
  182. Vastag, B. 2001. Pay attention: ritalin acts much like cocaine. JAMA 286 (8):905–6.
  183. Bailey Esq, B., Bad medicine, Texas Injury Law, July 27, 2008. http://www.txinjurylawblog.com/tags/drugs-accolate-accutane-arava-1/ (accessed January 30, 2009).
  184. Rosenthal, M. B., E. R. Berndt, J. M. Donohue, R. G. Frank, and A. M. Epstein. 2002. Promotion of prescription drugs to consumers. N Engl J Med 346 (7):498–505.
  185. Wolfe, S. M. 2002. Direct-to-consumer advertising—education or emotion promotion? N Engl J Med 346 (7):524–6.
  186. Ibid.
  187. Testimony and official submissions: PhRMA Chief Medical Officer testifies on DTC advertising, The Pharmaceutical Research and Manufacturers of America (PhRMA), 29 September 2005. http://www.phrma.org/publications/testimony_and_official_submissions/phrma_chief_medical_officer_testifies_on_direct-to-consumer_advertising/ (accessed January 29, 2009).
  188. Weissman, J. S., D. Blumenthal, A. J. Silk, M. Newman, K. Zapert, R. Leitman, and S. Feibelmann. 2004. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood) Suppl Web Exclusives:W4-219-33. http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.219v1 (accessed January 29, 2009).
  189. Kaiser Family Foundation, Menlo Park, CA. Prescription Drug Trends, Fact Sheet, June 2006.” http://www.kff.org/rxdrugs/upload/3057-05.pdf (accessed January 29, 2009).
  190. Loudon, Manette, interviewer. “The FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower,” parts of this interview appear in Gary Null’s documentary film, “Prescription for Disaster,” Garynull.com, August 30, 2005, reprinted by Natural News.http://www.naturalnews.com/011401.html (accessed January 31, 2009).
  191. US General Accounting Office. Report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives: FDA Drug Review Postapproval Risks 1976–85. Washington, DC: US General Accounting Office; 1990:3.
  192. Available at: www.msnbc.com/news/ 937302.asp?cp1=1. (accessed May 22, 2006).
  193. Suh, D. C., B. S. Woodall, S. K. Shin, and E. R. Hermes-De Santis. 2000. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 34 (12):1373–9.
  194. Ohlsen, K., T. Ternes, G. Werner, U. Wallner, D. Loffler, W. Ziebuhr, W. Witte, and J. Hacker. 2003. Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environ Microbiol 5 (8):711–6.
  195. Pawlowski, S., T. Ternes, M. Bonerz, T. Kluczka, B. van der Burg, H. Nau, L. Erdinger, and T. Braunbeck. 2003. Combined in situ and in vitro assessment of the estrogenic activity of sewage and surface water samples. Toxicol Sci 75 (1):57–65.
  196. Ternes, T. A., J. Stuber, N. Herrmann, D. McDowell, A. Ried, M. Kampmann, and B. Teiser. 2003. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res 37 (8):1976–82.
  197. Ternes, T. A., M. Meisenheimer, D. McDowell, F. Sacher, H. J. Brauch, B. Haist-Gulde, G. Preuss, U. Wilme, and N. Zulei-Seibert. 2002. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36 (17):3855–63.
  198. Ternes, T., M. Bonerz, and T. Schmidt. 2001. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 938 (1–2):175–85.
  199. Golet, E. M., A. C. Alder, A. Hartmann, T. A. Ternes, and W. Giger. 2001. Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal Chem 73 (15):3632–8.
  200. Daughton, C. G., and T. A. Ternes. 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107 Suppl 6:907–38.
  201. Hirsch, R., T. Ternes, K. Haberer, and K. L. Kratz. 1999. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225 (1–2):109–18.
  202. Ternes, T. A., M. Stumpf, J. Mueller, K. Haberer, R. D. Wilken, and M. Servos. 1999. Behavior and occurrence of estrogens in municipal sewage treatment plants—I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225 (1–2):81–90.
  203. Kaufman, M. Drugmaker to pay FDA $500 million. Manufacturing problems found at Schering-Plough. Washington Post. May 18, 2002:A01.
  204. Agger, W. A. 2002. Antibiotic resistance: unnatural selection in the office and on the farm. WMJ 101 (5):12–3.
  205. Nash, D. R., J. Harman, E. R. Wald, and K. J. Kelleher. 2002. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med 156 (11):1114–9.
  206. Schindler, C., J. Krappweis, I. Morgenstern, and W. Kirch. 2003. Prescriptions of systemic antibiotics for children in Germany aged between 0 and 6 years. Pharmacoepidemiol Drug Saf 12 (2):113–20.
  207. Finkelstein, J. A., C. Stille, J. Nordin, R. Davis, M. A. Raebel, D. Roblin, A. S. Go, D. Smith, C. C. Johnson, K. Kleinman, K. A. Chan, and R. Platt. 2003. Reduction in antibiotic use among US children, 1996–2000. Pediatrics 112 (3 Pt 1):620–7.
  208. Linder, J. A., and R. S. Stafford. 2001. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989–1999. JAMA 286 (10):1181–6.
  209. Available at: http://www.cdc.gov/drugresistance/community/. (accessed May 22, 2006).
  210. Rabin R. Caution about overuse of antibiotics. Newsday. September 18, 2003.
  211. Available at: http://www.cdc.gov/drugresistance/community/ (Accessed May 22, 2006).
  212. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  213. Available at: http://www.health.state.ok.us/ program/cdd/ar/. (accessed May 22, 2006).
  214. Available at: www.bayer.com/social-responsibility/health-projects/libra-initiative/page1193.htm. (accessed May 22, 2006).
  215. Agency for Healthcare Research and Quality, Rockville, MD. Health Care-Associated Infections. AHRQ Publication No. 08-M068, August 2008. http://www.ahrq.gov/qual/haiflyer.htm (accessed February 1, 2009).
  216. Coste, J., C. Hanotin, and E. Leutenegger. 1995. [Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: a survey of 1072 French general practitioners]. Therapie 50 (3):265–70.
  217. Kouyanou, K., C. E. Pither, and S. Wessely. 1997. Iatrogenic factors and chronic pain. Psychosom Med 59 (6):597–604.
  218. Hochman, JS. NSAID deaths. NSAIDs in the news, Our Chronic Pain Mission, 2003. http://www.cpmission.com/main/NSAIDSs2.html (accessed January 29, 2009).
  219. Li, D. K., L. Liu, and R. Odouli. 2003. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327 (7411):368. http://www.bmj.com/cgi/content/full/327/7411/368 (accessed January 29, 2009).
  220. Wilmington Star News (NC) Study: Painkillers can increase miscarriage risk. Wire article. 16 August 2003, NSAIDS in the news. http://www.cpmission.com/main/NSAIDs2.html; accessed January 29, 2009.
  221. Merck. Merck Announces Voluntary Worldwide Withdrawal of VIOXX, press release, September 30, 2004. http://www.merck.com/newsroom/vioxx_withdrawal/pdf/vioxx_press_release_final.pdfhttp://www.merck.com/newsroom/vioxx_withdrawal/pdf/vioxx_press_release_final.pdf (accessed January 29, 2009).
  222. Merck. Merck Announces Voluntary Worldwide Withdrawal of VIOXX, press release, September 30, 2004. http://www.merck.com/newsroom/vioxx_withdrawal/pdf/vioxx_press_release_final.pdfhttp://www.merck.com/newsroom/vioxx_withdrawal/pdf/vioxx_press_release_final.pdf (accessed January 29, 2009).
  223. Vioxx: Frequently Asked Questions, What is Vioxx? http://vioxxlawsuit.lawinfo.com/frequently-asked-vioxx-questions.html (accessed January 29, 2009); originally at http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699046.html.
  224. Juni, P., L. Nartey, S. Reichenbach, R. Sterchi, P. A. Dieppe, and M. Egger. 2004. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364 (9450):2021–9. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17514-4/fulltext (accessed January 29, 2009).
  225. Laurance, J. and S. Foley. Safety review ordered into popular painkillers, The Independent, 22 October 2004. http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/safety-review-ordered-into-popular-painkillers-544615.html (accessed January 29, 2009).
  226. US Senate Finance Committee. Testimony of David J. Graham, MD, MPH, November 18, 2004. http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf (accessed January 30, 2009).
  227. Sardi, Bill. Just How Many Americans Did Vioxx Kill? Lew Rockwell website, former congressional chief of staff to Ron Paul, M.D., April 21, 2006. http://www.lewrockwell.com/sardi/sardi53.html (accessed January 29, 2009).
  228. US Senate Finance Committee. Testimony of David J. Graham, MD, MPH, November 18, 2004. http://finance.senate.gov/hearings/testimony/2004test/111804dgtest.pdf (accessed January 30, 2009).
  229. Abel, U. 1992. Chemotherapy of advanced epithelial cancer—a critical review. Biomed Pharmacother 46 (10):439–52.
  230. Schulman, K. A., E. A. Stadtmauer, S. D. Reed, H. A. Glick, L. J. Goldstein, J. M. Pines, J. A. Jackman, S. Suzuki, M. J. Styler, P. A. Crilley, T. R. Klumpp, K. F. Mangan, and J. H. Glick. 2003. Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Bone Marrow Transplant 31 (3):205–10.
  231. Hassett, M. J., A. J. O’Malley, J. R. Pakes, J. P. Newhouse, and C. C. Earle. 2006. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98 (16):1108–17.
  232. Ibid.
  233. Ibid.
  234. Morgan, G., R. Ward, and M. Barton. 2004. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol (R Coll Radiol) 16 (8):549–60. Reports that “The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be…2.1%” in America.
  235. US Congressional House Subcommittee Oversight Investigation. Cost and Quality of Health Care: Unnecessary Surgery. Washington, DC: Government Printing Office; 1976. Cited in: McClelland GB, Foundation for Chiropractic Education and Research. Testimony to the Department of Veterans Affairs’ Chiropractic Advisory Committee. March 25, 2003.
  236. Leape LL. Unnecessary surgery. Health Serv Res. 1989 Aug;24(3):351–407.
  237. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  238. US Congressional House Subcommittee Oversight Investigation. Cost and Quality of Health Care: Unnecessary Surgery. Washington, DC: Government Printing Office; 1976. Cited in: McClelland GB, Foundation for Chiropractic Education and Research. Testimony to the Department of Veterans Affairs’ Chiropractic Advisory Committee. March 25, 2003.
  239. Leape LL. Unnecessary surgery. Health Serv Res. 1989 Aug; 24(3):351–407.
  240. US Congressional House Subcommittee Oversight Investigation. Cost and Quality of Health Care: Unnecessary Surgery. Washington, DC: Government Printing Office; 1976. Cited in: McClelland GB, Foundation for Chiropractic Education and Research. Testimony to the Department of Veterans Affairs’ Chiropractic Advisory Committee. March 25, 2003.
  241. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  242. McClelland GB, Foundation for Chiropractic Education and Research. Testimony to the Department of Veterans Affairs’ Chiropractic Advisory Committee. March 25, 2003.
  243. Coile, R. C., Jr. 2003. Internet-driven surgery. Russ Coiles Health Trends 15 (8):2–4.
  244. Guarner, V. 2000. [Unnecessary operations in the exercise of surgery. A topic of our times with serious implications in medical ethics]. Gac Med Mex 136 (2):183–8.
  245. Rutkow, I. M. 1987. Surgical operations in the United States: 1979 to 1984. Surgery 101 (2):192–200.
  246. Rutkow, I. M. 1997. Surgical operations in the United States. Then (1983) and now (1994). Arch Surg 132 (9):983–90.
  247. Linnemann, M. U., and H. H. Bulow. 1993. [Infections after insertion of epidural catheters]. Ugeskr Laeger 155 (30):2350–2.
  248. Seres, J. L., and R. I. Newman. 1989. Perspectives on surgical indications. Implications for controls. Clin J Pain 5 (2):131–6.
  249. Chassin, M. R., J. Kosecoff, R. E. Park, C. M. Winslow, K. L. Kahn, N. J. Merrick, J. Keesey, A. Fink, D. H. Solomon, and R. H. Brook. 1987. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 258 (18):2533–7.
  250. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  251. Leape LL. Unnecessary surgery. Health Serv Res. 1989 Aug; 24(3):351–407.
  252. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  253. Lazarou, J., B. H. Pomeranz, and P. N. Corey. 1998. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279 (15):1200–5.
  254. Innovations Exchange: Checklist-Plus-Technology System . . . , Enhances Required Preoperative Process Compliance, AHRQ, September 29, 2008. http://www.innovations.ahrq.gov/content.aspx?id=2262 (accessed February 1, 2009).
  255. Ibid.
  256. Houts, Marshall. Where Death Delights. (New York: Coward McCann, 1967), pp. 253–254.
  257. InjuryBoard.com. Virginia Has Special Medical Malpractice Law on Retained Surgical Towels, January 22, 2009. http://norfolk.injuryboard.com/medical-malpractice/virginia-has-special-medical-malpractice-law-on-retained-surgical-towels.aspx?googleid=255786 (accessed February 1, 2009).
  258. Ibid.
  259. Stark, K. and J. Goldstein, When surgical instruments are left behind - in patients: In the Phila. area, about 80 mistakes are made a year, Philadelphia Inquirer, February 1, 2004; reprinted by Committee for Justice for All.http://www.saynotocaps.org/newsarticles/When%20surgical%20instruments%20are%20left%20behind%20-%20in%20patients.htm (accessed February 1, 2009).
  260. InjuryBoard.com. Hospitals are Still Neglecting to Report Serious Mistakes—Are Medical Malpractice Lawsuits the Public’s Only Hope? InjuryBoard.com, January 30, 2009. http://cherryhill.injuryboard.com/medical-malpractice/hospitals-are-still-neglecting-to-report-serious-mistakes-are-medical-malpractice-lawsuits-the-publics-only-hope.aspx?googleid=256380 (accessed February 1, 2009).
  261. Haynes, A. B., M.D., M.P.H., (Harvard School of Public Health, Massachusetts General Hospital), et al., A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population, New England Journal of Medicine 360(5): 491–499, January 29, 2009. http://content.nejm.org/cgi/content/full/NEJMsa0810119 (accessed February 1, 2009).
  262. Nagourney, E, Checklist Reduces Deaths in Surgery, New York Times, January 14, 2009. http://www.nytimes.com/2009/01/20/health/20surgery.html (accessed February 1, 2009).
  263. Ibid.
  264. Office of Technology Assessment, US Congress. Assessing the Efficacy and Safety of Medical Technologies. Washington DC: Office of Technology Assessment, US Congress; 1978.
  265. Available at: www.wws.princeton.edu/ota/disk1/1995/9562_n.html. (accessed May 22, 2006).
  266. US Office of Technology Assessment. OTA Archive, August 1996. http://www.access.gpo.gov/ota/ (accessed February 1, 2009).
  267. InjuryBoard.com. Hospitals are Still Neglecting to Report Serious Mistakes - Are Medical Malpractice Lawsuits the Public’s Only Hope? InjuryBoard.com, January 30, 2009. http://cherryhill.injuryboard.com/medical-malpractice/hospitals-are-still-neglecting-to-report-serious-mistakes-are-medical-malpractice-lawsuits-the-publics-only-hope.aspx?googleid=256380 (accessed February 1, 2009).
  268. Ibid.
  269. Ibid.
  270. Zhan, C., and M. R. Miller. 2003. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 290 (14):1868–74.
  271. Available at: http://www.ahrq.gov/news/ ress/pr2003/injurypr.htm. (Accessed May 22, 2006).
  272. Weingart, S. N., and L. I. Iezzoni. 2003. Looking for medical injuries where the light is bright. JAMA 290 (14):1917–9.
  273. Macmahon, B. 1962. Prenatal x-ray exposure and childhood cancer. J Natl Cancer Inst 28:1173–91.
  274. Available at: http://hps.org/publicinformation/ate/q1084.html. (accessed May 22, 2006).
  275. Gofman, J.W. Radiation from Medical Procedures in the Pathogenesis of Cancer and Ischemic Heart Disease: Dose-Response Studies with Physicians per 100,000 Population. (San Francisco, CA: CNR Books, 1999).
  276. Gofman, J.W. Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of This Disease, 2nd ed. (San Francisco, CA: CNR Books, 1996).
  277. Twomly, R. “Full-Body Ct Screening: Preventing or Producing Cancer?” J Natl Cancer Inst96, no. 22 (2004): 1650–1.
  278. Ibid.
  279. Ibid.
  280. Sarno, J.E. Healing Back Pain: The Mind-Body Connection. Warner Books; 1991.
  281. http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  282. Siu, A. L., F. A. Sonnenberg, W. G. Manning, G. A. Goldberg, E. S. Bloomfield, J. P. Newhouse, and R. H. Brook. 1986. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med 315 (20):1259–66.
  283. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  284. Eriksen, B. O., I. S. Kristiansen, E. Nord, J. F. Pape, S. M. Almdahl, A. Hensrud, and S. Jaeger. 1999. The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med 246 (4):379–87.
  285. Siu, A. L., F. A. Sonnenberg, W. G. Manning, G. A. Goldberg, E. S. Bloomfield, J. P. Newhouse, and R. H. Brook. 1986. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med 315 (20):1259–66.
  286. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  287. Eriksen, B. O., I. S. Kristiansen, E. Nord, J. F. Pape, S. M. Almdahl, A. Hensrud, and S. Jaeger. 1999. The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med 246 (4):379–87.
  288. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  289. http://www.ahrq.gov/data/ hcup/hcupnet.htm. (accessed May 22, 2006).
  290. Siu, A. L., F. A. Sonnenberg, W. G. Manning, G. A. Goldberg, E. S. Bloomfield, J. P. Newhouse, and R. H. Brook. 1986. Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med 315 (20):1259–66.
  291. Siu, A. L., W. G. Manning, and B. Benjamin. 1990. Patient, provider and hospital characteristics associated with inappropriate hospitalization. Am J Public Health 80 (10):1253–6.
  292. Eriksen, B. O., I. S. Kristiansen, E. Nord, J. F. Pape, S. M. Almdahl, A. Hensrud, and S. Jaeger. 1999. The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine. J Intern Med 246 (4):379–87.
  293. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  294. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Morbidity and Mortality Weekly Report. February 25, 2000, Vol. 49, No. 7, p. 138.
  295. HealthGrades Quality Study: Patient Safety in American Hospitals, April 2004.
  296. Pittet, D., A. Simon, S. Hugonnet, C. L. Pessoa-Silva, V. Sauvan, and T. V. Perneger. 2004. Hand hygiene among physicians: performance, beliefs, and perceptions. Ann Intern Med 141 (1):1–8.
  297. HealthGrades Quality Study: Second Annual Patient Safety in American Hospitals, May 2005.
  298. Starfield, B. 2000. Is US health really the best in the world? JAMA 284 (4):483–5.
  299. Starfield, B. 2000. Deficiencies in US medical care. JAMA 284 (17):2184–5.
  300. Weingart, S. N., L. Wilson R. Mc, R. W. Gibberd, and B. Harrison. 2000. Epidemiology of medical error. West J Med 172 (6):390–3.
  301. Showalter, E. Hystories: Hysterical Epidemics and Modern Media. (New York: Columbia University Press, 1997).
  302. Available at: http://college.hmco.com/history/readerscomp/women/html/wh_001200_alternativeh.htm. (accessed May 16, 2006).
  303. Thacker, S.B., D. Stroup, M. Chang. Continuous electronic heart rate monitoring for fetal assessment during labor (Cochrane Review). In: The Cochrane Library, issue 1, 2003. Oxford: Update Software.
  304. Cole, C. 2003. Admission electronic fetal monitoring does not improve neonatal outcomes. J Fam Pract 52 (6):443–4.
  305. Nelson, H. D., L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan. 2002. Postmenopausal hormone replacement therapy: scientific review. JAMA 288 (7):872–81.
  306. Nelson, H. D. 2002. Assessing benefits and harms of hormone replacement therapy: clinical applications. JAMA 288 (7):882–4.
  307. Fletcher, S. W., and G. A. Colditz. 2002. Failure of estrogen plus progestin therapy for prevention. JAMA 288 (3):366–8.
  308. Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen, and J. Ockene. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288 (3):321–33.
  309. Hysterectomy prevalence and death rates for cervical cancer—United States, 1965–1988. 1992. MMWR Morb Mortal Wkly Rep 41 (2):17–20. http://www.cdc.gov/mmwr/preview/mmwrhtml/00015908.htm (accessed February 1, 2009).
  310. Rutkow, I. M. 1986. Obstetric and gynecologic operations in the United States, 1979 to 1984. Obstet Gynecol 67 (6):755–9.
  311. Family Practice News. February 15, 1995:29.
  312. Sakala, C. 1993. Medically unnecessary cesarean section births: introduction to a symposium. Soc Sci Med 37 (10):1177–98.
  313. VanHam, M.A., P.W. van Dongen, J. Mulder. Maternal consequences of cesarean section. A retrospective study of intraoperative and postoperative maternal complications of cesarean section during a 10-year period. Eur J Obstet Reprod Biol. 1997 Jul;74(1):1–6.
  314. Xakellis, G. C., R. Frantz, and A. Lewis. 1995. Cost of pressure ulcer prevention in long-term care. J Am Geriatr Soc 43 (5):496–501.
  315. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Bosley. 1997. Fourth national pressure ulcer prevalence survey. Adv Wound Care 10 (4):18–26.
  316. Available at: http://www.injuryboard.com/ view.cfm/Article=3005 (accessed May 22, 2006).
  317. Available at: http://www.cmwf.org/programs/elders/burger_mal_386.asp. (accessed May 22, 2006).
  318. Barczak, C. A., R. I. Barnett, E. J. Childs, and L. M. Bosley. 1997. Fourth national pressure ulcer prevalence survey. Adv Wound Care 10 (4):18–26.
  319. Kotulak, R. Doctors’ haste seen hurting patient: study says the push for quick treatment detracts from care. Chicago Tribune online edition, 10 May 2005. http://www.chicagotribune.com/features/health/ (no longer available here); available at Committee for Justice for All: Patient Safety and Doctor Discipline, CJA President Attorney Peter I. Fallk, Dr. Persell quote is on website. http://www.saynotocaps.org/patientsafety.shtml (accessed January 28, 2009).
  320. Available at: http://www.cmwf.org/programs/elders/burger_mal_386.asp. (accessed May 22, 2006).
  321. Available at: http://www.house.gov/waxman (accessed May 22, 2006).
  322. Mitka, M. 1998. Unacceptable nursing home deaths unautopsied. JAMA 280 (12):1038–9.
  323. Medical Review of North Carolina, Inc. New data is in on North Carolina’s nursing home residents. July 21, 2003.
  324. Weinstein, R. A. 1998. Nosocomial infection update. Emerg Infect Dis 4 (3):416–20.
  325. Available at: http://www.house.gov/waxman (accessed May 22, 2006).
  326. Available at: http://www.house.gov/waxman (accessed May 22, 2006).
  327. Centers for Medicare & Medicaid Services. Report to Congress: Appropriateness of Minimum Nurse Staffing Ratios in Nursing Homes: Phase II Final Report. December 24, 2001.
  328. National Citizens’ Coalition for Nursing Home Reform. Consumer group criticizes Thompson letter dismissing report on dangerous staffing levels in nursing homes [news release]. Washington, DC: March 22, 2002.
  329. Bergstrom, N., B. Braden, M. Kemp, M. Champagne, and E. Ruby. 1996. Multi-site study of incidence of pressure ulcers and the relationship between risk level, demographic characteristics, diagnoses, and prescription of preventive interventions. J Am Geriatr Soc 44 (1):22–30.
  330. Miles, S. H. 2002. Concealing accidental nursing home deaths. HEC Forum 14 (3):224–34.
  331. Corey, T. S., B. Weakley-Jones, G. R. Nichols, 2nd, and H. H. Theuer. 1992. Unnatural deaths in nursing home patients. J Forensic Sci 37 (1):222–7.
  332. Lloyd-Jones, D. M., D. O. Martin, M. G. Larson, and D. Levy. 1998. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129 (12):1020–6.
  333. Thomas, D. R., C. D. Zdrowski, M. M. Wilson, K. C. Conright, C. Lewis, S. Tariq, and J. E. Morley. 2002. Malnutrition in subacute care. Am J Clin Nutr 75 (2):308–13.
  334. Robinson, B. E. 1995. Death by destruction of will. Lest we forget. Arch Intern Med 155 (20):2250–1.
  335. Capezuti, E., N. E. Strumpf, L. K. Evans, J. A. Grisso, and G. Maislin. 1998. The relationship between physical restraint removal and falls and injuries among nursing home residents. J Gerontol A Biol Sci Med Sci 53 (1):M47–52.
  336. Phillips, C. D., C. Hawes, and B. E. Fries. 1993. Reducing the use of physical restraints in nursing homes: will it increase costs? Am J Public Health 83 (3):342–8.
  337. Miles, S. H., and P. Irvine. 1992. Deaths caused by physical restraints. Gerontologist 32 (6):762–6.
  338. Annas, G. J. 1999. The last resort—the use of physical restraints in medical emergencies. N Engl J Med 341 (18):1408–12.
  339. Parker, K., and S. H. Miles. 1997. Deaths caused by bedrails. J Am Geriatr Soc 45 (7):797–802.
  340. Katz, P. R., and G. Seidel. 1990. Nursing home autopsies. Survey of physician attitudes and practice patterns. Arch Pathol Lab Med 114 (2):145–7.
  341. Reuters Health. Overmedication of US seniors. May 21, 2003.
  342. Drug Benefit Trends. Average number of prescriptions by HMOs increases. 2002 Sep 12;14(8).
  343. Drug Benefit Trends. Average number of prescriptions by HMOs increases. 2002 Sep 12;14(8).
  344. Kaiser Family Foundation. Prescription Drug Trends. November, 2001.
  345. Williams, B. R., M. B. Nichol, B. Lowe, P. S. Yoon, J. S. McCombs, and J. Margolies. 1999. Medication use in residential care facilities for the elderly. Ann Pharmacother 33 (2):149–55.
  346. Available at: http://www.aarp.org/prescriptiondrugs (accessed May 22, 2006).
  347. Office of the Attorney General, Department of Justice, State of California. California reaches $100 million multi-state settlement with drug giant Mylan over alleged price-fixing scheme [press release]. Sacramento, CA; July 12, 2000.
  348. Available at: http://www.wral.com/money/2026364/detail.html (accessed May 22, 2006).
  349. Available at: www.education.guardian.co.uk/ businessofresearch/comment/ 0,9976,606260,00.html (accessed May 22, 2006).
  350. Available at: http://www.aarp.org/Articles/ a2003-03-07-supplements.html (accessed May 22, 2006).
  351. Bernabei, R., G. Gambassi, K. Lapane, F. Landi, C. Gatsonis, R. Dunlop, L. Lipsitz, K. Steel, and V. Mor. 1998. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279 (23):1877–82.
  352. Abel, U. 1992. Chemotherapy of advanced epithelial cancer—a critical review. Biomed Pharmacother 46 (10):439–52.
  353. World Health Organization. Press Release Bulletin #9. December 17, 2001.
  354. Angell, M. 2000. Is academic medicine for sale? N Engl J Med 342 (20):1516–8.
  355. McKenzie, J. Conflict of interest? Medical journal changes policy of finding independent doctors [transcript]. ABC News. June 12, 2002.
  356. Crossen C. Tainted Truth: The Manipulation of Fact in America. (New York: Simon & Schuster; 1994).
  357. Mundy A. Pressured, Schools Review Ties to Drug Firms, Wall Street Journal, September 11, 2008. http://online.wsj.com/article/SB122109019382321441.html (accessed January 28, 2009).
  358. Jalloh, A. C.U. Supports Disclosure of Univ. Research, The Cornell Daily Sun, October 7, 2008. http://cornellsun.com/section/news/content/2008/10/07/cu-supports-disclosure-univ-research-funding (accessed January 28, 2009).
  359. Medical News Today. Grassley, Kohl Say Public Should Know When Pharmaceutical Makers Give Money To Doctors, USA, September 8, 2007. http://www.medicalnewstoday.com/articles/81822.php (accessed January 28, 2009).
  360. Weiner, J. Smoking and cancer: the cigarette papers: how the industry is trying to smoke us all. The Nation. January 1, 1996:11–18.
  361. Available at: www.tobacco.org/resources/history/tobacco_history.html (acccessed May 22, 2006).
  362. Associated Press. Panel names estrogen as carcinogen. The Washington Post. December 16, 2000:A05.
  363. Cole, C. 2003. Admission electronic fetal monitoring does not improve neonatal outcomes. J Fam Pract 52 (6):443–4.
  364. MSNBC staff and wire reports. Estrogen hikes ovarian cancer risk. July 16, 2002. Grady D. Study recommends NOT using hormone therapy for bone loss. New York Times. October 1, 2003.
  365. Anderson, G. L., H. L. Judd, A. M. Kaunitz, D. H. Barad, S. A. Beresford, M. Pettinger, J. Liu, S. G. McNeeley, and A. M. Lopez. 2003. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA 290 (13):1739–48.
  366. Chlebowski, R. T., S. L. Hendrix, R. D. Langer, M. L. Stefanick, M. Gass, D. Lane, R. J. Rodabough, M. A. Gilligan, M. G. Cyr, C. A. Thomson, J. Khandekar, H. Petrovitch, and A. McTiernan. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA 289 (24):3243–53.
  367. Wassertheil-Smoller, S., S. L. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, A. Baird, T. Kotchen, J. D. Curb, H. Black, J. E. Rossouw, A. Aragaki, M. Safford, E. Stein, S. Laowattana, and W. J. Mysiw. 2003. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. JAMA 289 (20):2673–84.
  368. Shumaker, S. A., C. Legault, S. R. Rapp, L. Thal, R. B. Wallace, J. K. Ockene, S. L. Hendrix, B. N. Jones, 3rd, A. R. Assaf, R. D. Jackson, J. M. Kotchen, S. Wassertheil-Smoller, and J. Wactawski-Wende. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (20):2651–62.
  369. Beral, V. 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (9382):419–27.
  370. Nainggolan, L and C.Vega, MD. Breast Cancer Risk Remains After Stopping HRT, (based on the source Heiss, G., Wallace, R., Anderson, G.L., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299:1036–1045), Medscape Medical News, March 5, 2008; http://www.medscape.com/viewarticle/571032 (accessed February 1, 2009).